The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2017
Filed:
Feb. 25, 2015
Applicant:
Chang Gung Memorial Hospital, Keelung, Keelung, TW;
Inventors:
Assignee:
Chang Gung Memorial Hospital, Keelung, Keelung, TW;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4172 (2006.01); A61K 33/06 (2006.01); A61K 33/30 (2006.01); A61K 31/198 (2006.01); A61K 31/716 (2006.01); A61K 31/05 (2006.01); A61K 31/205 (2006.01); A61K 31/122 (2006.01); A61K 33/34 (2006.01); A61K 33/04 (2006.01); A61K 31/07 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/675 (2006.01); A61K 31/519 (2006.01); A61K 31/714 (2006.01); A61K 31/375 (2006.01); A61K 31/355 (2006.01); A61K 31/592 (2006.01); A61K 31/593 (2006.01); A61K 31/455 (2006.01); A61K 31/132 (2006.01); A61K 31/19 (2006.01); A61K 31/4415 (2006.01); A61K 31/59 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4172 (2013.01); A61K 31/05 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/132 (2013.01); A61K 31/19 (2013.01); A61K 31/198 (2013.01); A61K 31/205 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/59 (2013.01); A61K 31/592 (2013.01); A61K 31/593 (2013.01); A61K 31/675 (2013.01); A61K 31/714 (2013.01); A61K 31/716 (2013.01); A61K 33/04 (2013.01); A61K 33/06 (2013.01); A61K 33/30 (2013.01); A61K 33/34 (2013.01);
Abstract
The disclosure provides a nutritional composition for improving a patient with heart failure; the nutritional composition is consisting of therapeutically effective high amounts of leucine and histidine. The disclosure also provides the nutritional supplement comprising the nutritional composition, which may be a beverage product, a dietary supplement or food. The disclosure further provides a method of using the nutritional supplement for treating patients with heart failure.